logo dark logo light logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
mobile-logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
We are Company Builders

We are Company Builders

Identifying, incubating and growing future industry leaders in life sciences.

We are Industry Veterans

We are Industry Veterans

Capturing evolving healthcare trends and emerging cutting-edge innovations

We are Preferred Partners

We are Preferred Partners

Connecting companies with extensive network and resources globally and in China

  • Interius BioTherapeutics Announces Regulatory Approval to Expand Phase 1 Clinical Trial of INT2104 into Europe

    ...

    January 7, 2025
  • Avenzo Therapeutics and DualityBio Announce Exclusive Global License for Potential Best-In-Class EGFR/HER3 Antibody-Drug Conjugate

    ...

    January 7, 2025
  • Alebund Pharmaceutical announced the first closing of RMB 550 million in Series C financing

    ...

    January 7, 2025
All news

4560 Jinke Road, Jinchuang Plaza, Building 3, 8/F, Zhangjiang Hi-tech Park, Pudong, Shanghai, 201210 P.R. China
Phone: +86 21 6163 2598 | Fax: +86 21 6163 2570 | Email: info@quancapital.com

© Quan Capital. All rights reserved. Website Development. 沪ICP备18031693号-1